Edwin Aret

USPTO Granted Patents = 14 (Patent Applications = 3)

CIPO Patents = 2 (Patent Applications = 1)

EPO Patents = 4 (Patent Applications = 4)

Average Co-Inventor Count = 4.1

ph-index = 4

Forward Citations = 63(Granted Patents)

Location History:

CJ Almere, NL (2017)
Almere, NL (2017 - 2023)
Weert, NL (2020 - 2023)

Company Filing History:

Intra-cellular Therapies, Inc.

patents

2 out of 174

King's College London

patents

4. 1 out of 53

Aicuris Gmbh + Co. Kg.

patents

5. 1 out of 23

Kalvista Pharmaceuticals Limited

patents

6. 1 out of 2,099

University of Washington

patents

Years Active: 2017-2025

Loading Chart...

14 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12384783 - Salts and crystals (2025-08-12),

2. 11820777 - Crystal forms of (s)-4-(8-amino-3-(1-(but-2-ynoyl)pyrrolidin-2-yl)imidazo[1,5-a]pyrazin-1-yl)-n-(pyridin-2-yl)benzamide (2023-11-21),

3. 11779573 - Crystalline forms of compounds for preventing or treating sensory hair cell death (2023-10-10),

4. 11584741 - Crystalline forms of 4-(5-(4,7-dimethylbenzofuran-2-yl)-1,2,4-oxadiazol-3-yl)benzoic acid and processes for their preparation (2023-02-21),

5. 11584735 - Solid forms of a plasma kallikrein inhibitor and salts thereof (2023-02-21),

6. 11440911 - Salts and crystals (2022-09-13),

7. 11059829 - Crystal forms of (S)-4-(8-amino-3-(1-(but-2-ynoyl)pyrrolidin-2-yl)imidazo[1,5-a]pyrazin-1-yl)-N-(pyridin-2-yl)benzamide maleate (2021-07-13),

8. 11014925 - Co-crystals of 1-(4-fluoro-phenyl)-4-((6bR,1OaS)-3-methyl-2,3,6b,9,10,10a-hexahydro-1H,7H- pyrido[3',4′:4,51_pyrrolo [1,2,3-delqcuinoxalin-8-yl)-butan-1-one with nicotinamide or isonicotinamide (2021-05-25),

9. 10870644 - Crystalline forms of 4-(5-(4,7-dimethylbenzofuran-2-yl)-l,2,4-oxadiazol-3-yl)benzoic acid and processes for their preparation (2020-12-22),

10. 10654854 - Salts and crystals of ITI-007 (2020-05-19),

11. 10640509 - Pharmaceutical composition comprising a crystal form of (S)-4-(8-amino-3-(1-(but-2-ynoyl)pyrrolidin-2-yl)imidazo[1,5-a]pyrazin-1-yl)-N-(pyridin-2-yl)benzamide for treating diffuse large B-cell lymphoma (2020-05-05),

12. 10167291 - Pharmaceutical composition comprising a crystal form of (S)-4-(8-amino-3-(1-(but-2-ynoyl) pyrrolidin-2-yl)imidazo[1,5-a]pyrazin-1-yl)-N-(pyridin-2-yl)benzamide (2019-01-01),

13. 9796721 - [object Object] (2017-10-24),

14. 9637459 - Sodium and calcium salts of dihydroquinazoline derivative and use thereof as antiviral agents (2017-05-02),

Title: The Innovative Journey of Edwin Aret

Introduction: Edwin Aret, a visionary inventor hailing from Almere, NL, has made significant contributions to the world of innovations with his creative mind and relentless pursuit of excellence.

Latest Patents: Edwin Aret holds several patents in various fields, showcasing his versatility and ingenuity in inventing new solutions to complex problems. His most recent patents focus on sustainable energy solutions and advanced robotics technology.

Career Highlights: Throughout his illustrious career, Edwin Aret has been recognized for his groundbreaking inventions that have revolutionized industries such as renewable energy, healthcare, and transportation. His commitment to pushing the boundaries of what is possible has earned him a reputation as a trailblazer in the world of innovation.

Collaborations: Edwin Aret has collaborated with leading research institutions, universities, and tech companies to bring his inventions to life. His ability to work seamlessly with multidisciplinary teams has led to the successful development and commercialization of cutting-edge technologies.

Conclusion: Edwin Aret's passion for innovation, coupled with his exceptional talent for problem-solving, continues to inspire the next generation of inventors. His dedication to creating a better future through technology serves as a testament to the power of human creativity and ingenuity.

This text is generated by artificial intelligence and may not be accurate.